Literature DB >> 3518703

Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.

E Ranieri, B Paton, A Poulos.   

Abstract

Activator protein (AP), which stimulated fibroblast sphingomyelinase activity, was isolated from the spleen of a patient with Gaucher's disease type I by the combined techniques of heat and alcohol denaturation, DEAE-cellulose column chromatography, gel filtration, preparative polyacrylamide-gel electrophoresis and decyl-agarose chromatography. Urea/sodium dodecyl sulphate (SDS)/polyacrylamide-gel electrophoresis showed two bands, one with an Mr of approx. 3,000 and the other with an Mr of 5,000-6,500. Similarly, SDS/polyacrylamide-gel electrophoresis performed in the absence of urea revealed the presence of two components, one of which adsorbed to a concanavalin A (Con A) column. Both components stimulated sphingomyelinase activity. On a non-denaturing polyacrylamide gel containing Triton X-100, four major components, two of which bound to Con A, were detected with the dye Stains-All. Cross-reacting material (CRM) to polyclonal Gaucher spleen AP antibodies was detected in normal fibroblasts and in fibroblasts from patients with sphingomyelinase and beta-glucocerebrosidase deficiency states (Niemann-Pick and Gaucher's diseases respectively). CRM in normal fibroblasts adsorbed to Con A columns and had the same mobility on SDS/polyacrylamide-gel electrophoresis as Con A-adsorbing Gaucher spleen AP. Normal AP was not observed in mucolipidosis type II (I-cell disease) fibroblasts; instead, extracts from these cells revealed the presence of two closely migrating bands with higher Mr values than normal fibroblast CRM. Furthermore, extracts of media from I-cell fibroblast cultures, but not from control or Gaucher fibroblast cultures, contained AP activity towards sphingomyelinase and beta-glucocerebrosidase. Fibroblasts from a patient with mucolipidosis type III (pseudo-Hurler polydystrophy) showed an intermediate pattern consisting of normal as well as the higher-Mr CRM. Our data provide evidence for the existence of AP in cultured skin fibroblasts and suggest that these proteins may be targetted to the lysosome by post-translational modification in a similar manner to that reported for lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518703      PMCID: PMC1153097          DOI: 10.1042/bj2330763

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  The cohydrolases in human spleen that stimulate glucosyl ceramide beta-glucosidase.

Authors:  S S Iyer; S L Berent; N S Radin
Journal:  Biochim Biophys Acta       Date:  1983-10-17

3.  Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.

Authors:  A Poulos; E Ranieri; P Shankaran; J W Callahan
Journal:  Biochim Biophys Acta       Date:  1984-04-18

4.  Defective phosphorylation and processing of beta-hexosaminidase by intact cultured fibroblasts from patients with mucolipidosis III.

Authors:  P G Robey; E F Neufeld
Journal:  Arch Biochem Biophys       Date:  1982-01       Impact factor: 4.013

5.  A new variant of type-AB GM2-gangliosidosis.

Authors:  S C Li; Y Hirabayashi; Y T Li
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

6.  Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.

Authors:  K Inui; D A Wenger
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

7.  Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.

Authors:  K Inui; M Emmett; D A Wenger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.

Authors:  R Varon; W J Kleijer; E J Thompson; A d'Azzo
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.

Authors:  P Hechtman; B A Gordon; N M Ng Ying Kin
Journal:  Pediatr Res       Date:  1982-03       Impact factor: 3.756

10.  A protein activator of galactosylceramide beta-galactosidase.

Authors:  D A Wenger; M Sattler; S Roth
Journal:  Biochim Biophys Acta       Date:  1982-09-14
View more
  3 in total

1.  Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.

Authors:  B C Paton; A Poulos
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

2.  Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.

Authors:  W Schlote; K Harzer; H Christomanou; B C Paton; B Kustermann-Kuhn; B Schmid; J Seeger; U Beudt; I Schuster; U Langenbeck
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

Review 3.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.